In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Henriques, Cristina ^a,b,c   Henriques Pons, Andréa ^c   Meuser Batista, Marcelo ^c   Ribeiro, Aline Salgado ^c   De Souza, Wanderley ^a,b,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Biomagens INBEB   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

Bioluminescence; Chagas disease; Heart; Luciferase; Mice; Rectum; Testicles; Trypanosoma cruzi

Indexed keywords

FIREFLY LUCIFERASE; ISOFLURANE; LUCIFERASE; LUCIFERIN; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE COURSE; EX VIVO STUDY; FACE; FORELIMB; GONAD; IN VIVO STUDY; INOCULATION; LARGE INTESTINE; LIMB; MALE; MICROSCOPY; MOUSE; MUSCLE CELL; NONHUMAN; PARASITE; PERITONEAL CAVITY; RECTUM; TRYPANOSOMA CRUZI; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; LUMINESCENCE; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PROCEDURES; STAINING; TRYPANOSOMIASIS;

ANIMALIA; MAMMALIA; MUS; TRYPANOSOMA CRUZI;

ANIMALS; CELL LINE; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED BALB C; STAINING AND LABELING; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 84897992899     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-89     Document Type: Article

References (35)

1. World Health Organization, Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases Geneva: World Health Organization 2010 WHO/HTM/NTD/2010.1
2. Review on Trypanosoma cruzi: host cell interaction. De Souza W, Carvalho TMU, Barrias ES, Int J Cell Biol 2010 2010 295394 doi: 10.1155/2010/295394 20811486
3. The adipocyte as an important target cell for Trypanosoma cruzi infection. Combs TP, Nagajyothi, Mukherjee S, de Almeida CJ, Jelicks LA, Schubert W, Lin Y, Jayabalan DS, Zhao D, Braunstein VL, Landskroner-Eiger S, Cordero A, Factor SM, Weiss LM, Lisanti MP, Tanowitz HB, Scherer PE, J Biol Chem 2005 280 24085 24094 10.1074/jbc.M412802200 15843370 (Pubitemid 40884896)
4. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A, Ann Intern Med 2006 144 724 734 10.7326/0003-4819-144-10-200605160-00006 16702588 (Pubitemid 46780632)
5. Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Nagajyothi F, Machado FS, Burleigh BA, Jelicks LA, Scherer PE, Mukherjee S, Lisanti MP, Weiss LM, Garg NJ, Tanowitz HB, Cell Microbiol 2012 14 634 643 10.1111/j.1462-5822.2012.01764.x 22309180
6. Screening of potential anti-trypanosoma cruzi candidates: In vitro and In vivo studies. Soeiro MN, de Castro SL, Open Med Chem J 2011 5 21 30 21629508
7. Investigation of a protein expression profile by high-resolution bidimensional electrophoresis of Trypanosoma cruzi epimastigotes. Souza RA, Henriques C, Alves-Ferreira M, Mendonça-Lima L, Degrave WM, Anal Biochem 2007 365 144 146 10.1016/j.ab.2007.01.011 17418799 (Pubitemid 46617459)
8. Proteomics in Trypanosoma cruzi-localization of novel proteins to various organelles. Ferella M, Nilsson D, Darban H, Rodrigues C, Bontempi EJ, Docampo R, Andersson B, Proteomics 2008 8 2735 2749 10.1002/pmic.200700940 18546153 (Pubitemid 351988577)
9. A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information. Alves-Ferreira M, Guimarães AC, Capriles PV, Dardenne LE, Degrave WM, Mem Inst Oswaldo Cruz 2009 2009 104 1100 1110
10. Tetrazolium salt based methods for high-throughput evaluation of anti-parasite chemotherapy. Henriques C, Moreira TLB, Maia-Brigagão C, Henriques-Pons A, Carvalho TMU, de Souza W, Anal Methods 2011 3 2148 2155 10.1039/c1ay05219e
11. Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening. Andriani G, Chessler AD, Courtemanche G, Burleigh BA, Rodriguez A, PLoS Negl Trop Dis 2011 5 1298 10.1371/journal.pntd.0001298 21912715
12. Bioluminescent imaging of Trypanosoma cruzi infection in Rhodnius prolixus. Henriques C, Castro DP, Gomes LH, Garcia ES, de Souza W, Parasit Vectors 2012 5 214 10.1186/1756-3305-5-214 23013827
13. In vivo imaging of Transgenic leishmania parasites in a live host. Thalhofer CJ, Graff JW, Love-Homan L, Hickerson SM, Craft N, Beverley SM, Wilson ME, J Vis Exp 2010 41 1980
14. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC, Infect Immun 2005 73 695 702 10.1128/IAI.73.2.695- 702.2005 15664907 (Pubitemid 40165724)
15. Growth and differentiation in Trypanosoma cruzi. Camargo EP, Rev Inst Med São Paulo 1964 6 93 100
16. In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S, Mol Biochem Parasitol 1985 16 315 327 10.1016/0166-6851(85)90073-8 3903496 (Pubitemid 16248528)
17. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Brener Z, Rev Inst Med Trop Sao Paulo 1962 4 389 396 14015230
18. Functional analysis of the intergenic region of TcP2β gene loci allowed the construction of a improved Trypanosoma cruzi expression vector. Vazquez MP, Levin MJ, Gene 1999 239 217 225 10.1016/S0378-1119(99)00386-8 10548722 (Pubitemid 29512351)
19. Gene replacement in parasitic protozoa. Cruz A, Beverley SM, Nature 1990 348 171 173 10.1038/348171a0 2234081 (Pubitemid 20368919)
20. Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice. Andrade SG, Mem Inst Oswaldo Cruz 1990 85 17 27 10.1590/S0074-02761990000100003 2215229
21. Araújo-Jorge T, (ORG). Doença de Chagas: Manual para experimentação animal Rio de Janeiro: Editora Fiocruz / Instituto Oswaldo Cruz 2000 368
22. Trypanosoma cruzi infection: do distinct populations cause intestinal motility alteration? Medeiros MM, Araújo-Jorge TC, Batista WS, da Silva TMOA, de Souza AP, Parasitol Res 2010 107 239 242 10.1007/s00436-010-1871-5 20454805
23. Trypanosoma cruzi-cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo. Calvet CM, Meuser M, Almeida D, Meirelles MN, Pereira MC, Exp Parasitol 2004 107 20 30 10.1016/j.exppara.2004.04.003 15208034 (Pubitemid 38781069)
24. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Gutierrez FR, Mineo TW, Pavanelli WR, Guedes PM, Silva JS, Mem Inst Oswaldo Cruz 2009 104 236 245 19753479
25. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Arantes RM, Marche HH, Bahia MT, Cunha FQ, Rossi MA, Silva JS, Am J Pathol 2004 164 1361 1368 10.1016/S0002-9440(10)63222-1 15039223 (Pubitemid 38387801)
26. Presence of Trypanosoma cruzi in the anal glands of naturally infected opossum (didelphis Marsupialis) in the state of Santa Catarina Brazil. Steindel M, Scholz AF, Toma HK, Schlemper BR Jr, Mem Inst Oswaldo Cruz 1988 83 135 137 10.1590/S0074-02761988000100017 3074238
27. Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study. Andrade LO, Galvão LM, Meirelles Mde N, Chiari E, Pena SD, Macedo AM, Mem Inst Oswaldo Cruz 2010 105 834 837 20945002
28. Mexican Trypanosoma cruzi T. cruzi I strains with different degrees of virulence induce diverse humoral and cellular immune responses in a murine experimental infection model. Espinoza B, Rico T, Sosa S, Oaxaca E, Vizcaino-Castillo A, Caballero ML, Martínez I, J Biomed Biotechnol 2010 2010 890672 doi: 10.1155/2010/890672 20396398
29. Bioluminescent imaging of Trypanosoma cruzi infection. Hyland KV, Asfaw SH, Olson CL, Daniels MD, Engman DM, Int J Parasitol 2008 38 12 1391 1400 10.1016/j.ijpara.2008.04.002 18511053
30. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. Canavaci AMC, Bustamante JM, Padilla AM, Perez Brandan CM, Simpson LJ, Xu D, Boehlke CL, Tarleton RL, PLoS Neglected Trop Disease 2010 4 740 10.1371/journal.pntd.0000740
31. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG, Mem Inst Oswaldo Cruz 2009 104 1051 1054 10.1590/S0074-02762009000700021 20027478
32. Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) through the implementation of High-Resolution Melting (HRM) genotyping assay. Higuera SL, Guhl F, Ramírez JD, Parasit Vectors 2013 6 112 10.1186/1756-3305-6- 112 23602078
33. Household risk factors for Trypanosoma cruzi seropositivity in two geographic regions of Ecuador. Black CL, Ocanã S, Riner D, Costales JA, Lascano MS, Davila S, Arcos-Teran L, Seed JR, Grijalva MJ, J Parasitol 2007 93 12 16 10.1645/GE-899R.1 17436937 (Pubitemid 46625534)
34. Trypanosoma cruzi: biological characterization of lineages I and II supports the predominance of lineage I in Colombia. Mejía-Jaramillo AM, Penã VH, Triana-Chávez O, Exp Parasitol 2009 121 83 91 10.1016/j.exppara.2008.10.002 18950627
35. Geographical distribution of Trypanosoma cruzi genotypes in Venezuela. Carrasco HJ, Segovia M, Llewellyn MS, Morocoima A, Urdaneta-Morales S, Martínez C, Martínez CE, Garcia C, Rodríguez M, Espinosa R, de Noya BA, Díaz-Bello Z, Herrera L, Fitzpatrick S, Yeo M, Miles MA, Feliciangeli MD, PLoS Negl Trop Dis 2012 6 1707 10.1371/journal.pntd.0001707 22745843